China's Philanthropic Gestures, Genomic Technologies, and the Imminent Setbacks in Developing Nations

China's Philanthropic Gestures, Genomic Technologies, and the Imminent Setbacks in Developing Nations

Copyright: © 2015 |Pages: 27
DOI: 10.4018/978-1-4666-8559-8.ch011


This study focused on the trajectory of the human genome sequencing and the emanating technologies developed to address the leading causes of death in the industrialized nations. It also examined the flourishing biotechnology and industrial startup companies established for wealth creation. However, in the developing and least-developed nations, we discussed the inability of these nations to have access to capital, the Internet and other telecommunication network to create quadripartite linkage among governments, industries, universities, venture capitalists who create local startup companies. The need to ingeniously revise, and develop innovative technologically-oriented curricula in their academic institutions was emphasized. By far most important, they must invest intellectual resources to eliminate the existing barriers between scientific disciplines and behavioral sciences, because genomics is an eclectic science. Expert committees formed from these intellectual groups could devise the strategies and recommendations to eliminate poverty, reduce unemployment and eventually create badly needed national wealth.
Chapter Preview

Part I: Innovating Genomic Technologies In Developing Nations


Over the years, China has also established a viable genomic institute; and the government continues to invest colossal sums of money to develop authentic technologies and build competent molecular sciences workforce. Recently, the high-speed large capacity disk array system was installed in of the nation’s genomic institutes. This computational machine was developed to handle copious amounts of data and maintain the capacity to save such data. Besides the data backup capability, their new computer has the capacity to protect sensitive research data from unexpected loss. The intrinsic goal of the Chinese human genome center has been to contribute to human society through the development of efficient diagnosis of illnesses, prevention and the application of effective therapeutic interventions to meet the needs of the society.

The Beijing Genomic Institute (BGI) is one of China’s leading research facilities on throughput sequencing-based profiling tools, and the institute is committed to excellence in genome sciences. BGI continues to conduct a large-scale genomic research in bioinformatics, genome dynamics, and genotyping with over 100 bioinformatics specialists. Research scientists at BGI have focused their investigations on the Human HapMap project, the super-hybrid Rice Genome project, silkworm genome, chicken genome variation in collaboration with United Kingdom and United States partners and the Sino-Danish pig genome project.

Other technologically savvy developing nations such as Brazil, Korea, and India have directed their research interest on their pharmaceutical industry; systematically using genomic science and bioinformatics to develop agriculture, chemicals, biodefense, and energy. Brazil now leads the world in biofuels and the prevention of citrus diseases. Korea continues to invest in cloning and tissue engineering. As these technological initiatives occur at exponential rate in the developed nations, we continue to observe imminent setbacks in developing and underdeveloped nations.

Complete Chapter List

Search this Book: